| Product |
CAS |
Molecular formula |
More |
| Prasugrel alpha-hydroxy impurity |
1100905-45-0 |
|
More |
| Prasugrel metabolite derivative-13c-d3 (trans r-138727mp, mixture of d |
1217234-50-8 |
|
More |
| Prasugrel impurity (1-bromo-5-chloro-1-(2-fluorophenyl)pentan-2-one) |
1373350-58-3 |
C11H11BrClFO |
More |
| Prasugrel metabolite r-138727 |
204204-73-9 |
C18H20FNO3S |
More |
| 4-Oxo-8-[4-(4-phenylbutoxy)benzoylamino]-4h-1-benzopyran-2-carboxylic |
211116-98-2 |
C27H23NO6 |
More |
| 4-Oxo-8-[4-(4-phenylbutoxy)benzoylamino]-4h-1-benzopyran-2-carboxamide |
136450-10-7 |
C27H24N2O5 |
More |
| Phenytoin impurity e |
6802-95-5 |
C15H14N2O3 |
More |
| 4’-Ethoxyacetophenone |
1676-63-7 |
C10H12O2 |
More |
| 3-Hydroxy-n-methylpyridinium bromide (pyridostigmine related compound |
31034-86-3 |
C6H8NO.Br |
More |
| Praziquantel related compound b |
125273-86-1 |
C19H22N2O2 |
More |
| Praziquantel related compound c |
125273-88-3 |
C19H22N2O4 |
More |
| (3R, 5r)-pitavastatin calcium salt |
254452-96-5 |
C25H24FNO4 |
More |
| (3S,5s)-pitavastatin calcium salt |
254452-92-1 |
C25H24FNO4 |
More |
| (3S,5r)-pitavastatin calcium |
254452-88-5 |
C25H24FNO4 |
More |
| Pmpa-d3 |
172023-63-1 |
|
More |
| Paliperidone impurity h |
1388021-47-3 |
|
More |
| Paliperidone impurity f |
1380413-60-4 |
|
More |
| Paliperidone impurity g |
1388021-46-2 |
|
More |
| Pemetrexed impurity (mixture of diastereomers) (n-[4-[2-(2-amino-4,5,6 |
193281-00-4 |
C20H21N5O7 |
More |
| Pemetrexed l-glutamic acid trisodium |
1265908-59-5 |
C25H25N6Na3O9 |
More |
